drugset
drugset / Trial / NCT00538889

Study Evaluating a Combined Administration of Lecozotan SR and Citalopram in Young Healthy Subjects

NCT00538889 ↗

Phase 1 Completed 40 enrolled Wyeth is now a wholly owned subsidiary of Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

To assess the safety and tolerability of lecozotan SR and citalopram when coadministred to healthy subjects.

Timeline

Start
2007-08
Primary completion
—
Completion
2007-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Citalopram Small molecule — —
Subject Lecozotan Small molecule — —

Indications

No indication recorded.